Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oxymorphone Extended-Release Tablets (Opana ER) For the Management of Chronic Pain: A Practical Review for Pharmacists.

Literature DB >> 20592876

Oxymorphone Extended-Release Tablets (Opana ER) For the Management of Chronic Pain: A Practical Review for Pharmacists.

David S Craig¹.

Abstract

Entities: Chemical Disease

Keywords: chronic pain; opioid; opioid rotation; opioid switching; oxymorphone

Year: 2010 PMID： 20592876 PMCID： PMC2888551

Source DB: PubMed Journal: P T ISSN： 1052-1372

Keyword Cloud
References

× No keyword cloud information.

41 in total

1. Opioid prescribing practices in chronic pain management: guidelines do not sufficiently influence clinical practice.

Authors: Timothy W Victor; Nancy A Alvarez; Errol Gould
Journal: J Pain Date: 2009-10 Impact factor: 5.820

2. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study.

Authors: Martin E Hale; Harry Ahdieh; Tina Ma; Richard Rauck
Journal: J Pain Date: 2006-12-04 Impact factor: 5.820

3. No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients.

Authors: Julia Riley; Joy R Ross; Dag Rutter; Athol U Wells; Katherine Goller; Ron du Bois; Ken Welsh
Journal: Support Care Cancer Date: 2005-06-11 Impact factor: 3.603

4. The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated.

Authors: Fraser B Ross; Maree T Smith
Journal: Pain Date: 1997-11 Impact factor: 6.961

5. Identification of hydrocodone in human urine following controlled codeine administration.

Authors: J M Oyler; E J Cone; R E Joseph; M A Huestis
Journal: J Anal Toxicol Date: 2000-10 Impact factor: 3.367

6. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors: Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal: J Pain Date: 2009-02 Impact factor: 5.820

Oxymorphone Extended-Release Tablets (Opana ER) For the Management of Chronic Pain: A Practical Review for Pharmacists.

1. Opioid prescribing practices in chronic pain management: guidelines do not sufficiently influence clinical practice.

2. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study.

3. No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients.

4. The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated.

5. Identification of hydrocodone in human urine following controlled codeine administration.

6. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

7. A feasibility study of a combined nurse/pharmacist-led chronic pain clinic in primary care.

8. CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.

9. Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan.

Review 10. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden.